Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC-NDNature Cancer

ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression

31 more authors
26 affiliations
  1. 1Equipe de Recherche Labellisée "Ligue Contre le Cancer", INSERM UMR-1037, CNRS ERL5294, Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse, Toulouse, France
  2. 2Program in Cancer Signaling & Microenvironment, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA
  3. 3The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA
  4. 4Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse, INSERM UMR-107, CNRS ERL5294, Equipe de Recherche Labellisée "Ligue Contre le Cancer", Toulouse, France
  5. 5Program in Cancer Signaling & Microenvironment, Fox Chase Cancer Center, Philadelphia, PA 9, USA
  6. 6The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA
  7. 7Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
  8. 8Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 1910, USA
  9. 9Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
  10. 10Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA
  11. 11Department of Bioengineering, Temple University, Philadelphia, PA, 19140, USA
  12. 12Bioengineering Department, College of Engineering, Temple University, Philadelphia, PA, USA
  13. 13Molecular and Cell Biology and Genetics (MCBG) Program, Drexel University College of Medicine, Philadelphia, PA 19102, USA
  14. 14Henry Ford Pancreatic Cancer Center, Detroit, MI, USA
  15. 15Molecular and Cell Biology and Genetics (MCBG) Program, Drexel University College of Medicine, Philadelphia, PA, USA
  16. 16Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Philadelphia, PA 19104, USA
  17. 17Hôpital Beaujon - INSERM U114 - Clichy, France
  18. 18Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA
  19. 19Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Philadelphia, PA, USA
  20. 20Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
  21. 21Hôpital Beaujon, INSERM, Clichy, France
  22. 22Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Philadelphia, PA, USA
  23. 23Program in Cancer Signaling & Microenvironment, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. [email protected]
  24. 24The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA. [email protected]
  25. 25Program in Cancer Signaling & Microenvironment, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. [email protected]
  26. 26The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA. [email protected]

Abstract

In pancreatic ductal adenocarcinoma (PDAC), the fibroblastic stroma constitutes most of the tumor mass and is remarkably devoid of functional blood vessels. This raises an unresolved question of how PDAC cells obtain essential metabolites and water-insoluble lipids. We have found a critical role for cancer-associated fibroblasts (CAFs) in obtaining and transferring lipids from blood-borne particles to PDAC cells via trogocytosis of CAF plasma membranes. We have also determined that CAF-expressed phospholipid scramblase anoctamin 6 (ANO6) is an essential CAF trogocytosis regulator required to promote PDAC cell survival. During trogocytosis, cancer cells and CAFs form synapse-like plasma membranes contacts that induce cytosolic calcium influx in CAFs via Orai channels. This influx activates ANO6 and results in phosphatidylserine exposure on CAF plasma membrane initiating trogocytosis and transfer of membrane lipids, including cholesterol, to PDAC cells. Importantly, ANO6-dependent trogocytosis also supports the immunosuppressive function of pancreatic CAFs towards cytotoxic T cells by promoting transfer of excessive amounts of cholesterol. Further, blockade of ANO6 antagonizes tumor growth via disruption of delivery of exogenous cholesterol to cancer cells and reverses immune suppression suggesting a potential new strategy for PDAC therapy.

Related

  1. From CAF subtypes to clinically relevant states: cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
    Yi Hao, Yi Wang, Qinyang Du +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  2. Human microglia clear intraneuronal α-synuclein aggregates by GPNMB-mediated trogocytosis.
    Hung-Ju Chueh, Antigoni Katsikoudi, Ana Aragón-González +7
    Science translational medicinePeer-reviewedCC BYFull textNeurologyEurope PMC
  3. Spatial multi-omics resolve epithelium-fibroblast gradients and highlight NESTIN-NOTCH1-expressing subepithelial fibroblasts during human pancreatic tumorigenesis
    M. Batardiere, M. I. Ibanez-Rios, A. Khellaf +25
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Three-dimensional culture suppresses pancreatic fibroblast activation and limits paracrine signaling between pancreatic cancer cells and fibroblasts
    Nino Javakhishvili, Anais Zourelidis, Bogusz Trojanowicz +2
    Biochemistry and Biophysics ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  5. Claudin‐12‐Expressing Fibroblasts Facilitate Metastatic Spread of Pancreatic Cancer Through Physical Interactions
    Qingcui Li, Xiangjing Miao, Yuanyuan Yang +9
    MedCommPeer-reviewedCC BYFull textOncologyEurope PMCPMC
BibTeX
@article{ogier2026ano6mediated,
  title = {{ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression}},
  author = {Charline Ogier and Charles Solomon Akino Mercy and Elena Bondarenko and Zhijing Wu and Zhen Lu and Quoc Thang Bui and Mayura R. Dhamdhere and Yingying Tang and Ludmila Recoules and Alena Klochkova and Linara Gabitova-Cornell and Battuya Bayarmagnai and Diana Restifo and Aizhan Surumbayeva and Debora Barbosa Vendramini Costa and Alexander Y. Deneka and Ralph Francescone and Anna C. Lilly and Alyssa Sipman and Jaye C. Gardiner and Tiffany Luong and Janusz Franco‐Barraza and Alexander A. Dolskiy and Mariia Dmitrieva and Kathy Qi Cai and Margret B. Einarson and Emmanuelle Nicolas and Andrei Efimov and Emily Megill and Nathaniel W. Snyder and Sven Miller and Mark Andrake and Natalie Phinney and Rolf A. Brekken and Jerome F. Cros and Erica A. Golemis and Yunyun Zhou and Bojana Gligorijevic and Corinne Bousquet and Jonathan Soboloff and Serge Yu. Fuchs and Edna Cukierman and Igor A. Astsaturov},
  journal = {Nature Cancer},
  year = {2026},
  month = oct,
  doi = {10.1038/s43018-026-01265-5},
  url = {https://doi.org/10.1038/s43018-026-01265-5},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression
AU  - Charline Ogier
AU  - Charles Solomon Akino Mercy
AU  - Elena Bondarenko
AU  - Zhijing Wu
AU  - Zhen Lu
AU  - Quoc Thang Bui
AU  - Mayura R. Dhamdhere
AU  - Yingying Tang
AU  - Ludmila Recoules
AU  - Alena Klochkova
AU  - Linara Gabitova-Cornell
AU  - Battuya Bayarmagnai
AU  - Diana Restifo
AU  - Aizhan Surumbayeva
AU  - Debora Barbosa Vendramini Costa
AU  - Alexander Y. Deneka
AU  - Ralph Francescone
AU  - Anna C. Lilly
AU  - Alyssa Sipman
AU  - Jaye C. Gardiner
AU  - Tiffany Luong
AU  - Janusz Franco‐Barraza
AU  - Alexander A. Dolskiy
AU  - Mariia Dmitrieva
AU  - Kathy Qi Cai
AU  - Margret B. Einarson
AU  - Emmanuelle Nicolas
AU  - Andrei Efimov
AU  - Emily Megill
AU  - Nathaniel W. Snyder
AU  - Sven Miller
AU  - Mark Andrake
AU  - Natalie Phinney
AU  - Rolf A. Brekken
AU  - Jerome F. Cros
AU  - Erica A. Golemis
AU  - Yunyun Zhou
AU  - Bojana Gligorijevic
AU  - Corinne Bousquet
AU  - Jonathan Soboloff
AU  - Serge Yu. Fuchs
AU  - Edna Cukierman
AU  - Igor A. Astsaturov
PY  - 2026
DA  - 2026/10/30
JO  - Nature Cancer
DO  - 10.1038/s43018-026-01265-5
UR  - https://doi.org/10.1038/s43018-026-01265-5
AB  - In pancreatic ductal adenocarcinoma (PDAC), the fibroblastic stroma constitutes most of the tumor mass and is remarkably devoid of functional blood vessels. This raises an unresolved question of how PDAC cells obtain essential metabolites and water-insoluble lipids. We have found a critical role for cancer-associated fibroblasts (CAFs) in obtaining and transferring lipids from blood-borne particles to PDAC cells via trogocytosis of CAF plasma membranes. We have also determined that CAF-expressed phospholipid scramblase anoctamin 6 (ANO6) is an essential CAF trogocytosis regulator required to promote PDAC cell survival. During trogocytosis, cancer cells and CAFs form synapse-like plasma membranes contacts that induce cytosolic calcium influx in CAFs via Orai channels. This influx activates ANO6 and results in phosphatidylserine exposure on CAF plasma membrane initiating trogocytosis and transfer of membrane lipids, including cholesterol, to PDAC cells. Importantly, ANO6-dependent trogocytosis also supports the immunosuppressive function of pancreatic CAFs towards cytotoxic T cells by promoting transfer of excessive amounts of cholesterol. Further, blockade of ANO6 antagonizes tumor growth via disruption of delivery of exogenous cholesterol to cancer cells and reverses immune suppression suggesting a potential new strategy for PDAC therapy.
SN  - 2662-1347
ER  -